The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In this webinar brought to you by Lonza, Ethan Shelkey and Aurita Menezes will discuss the effects of donor variability in cell-based assays for measuring drug immunogenicity and immunotoxicity. The ...

label-free confocal imaging for live and kinetic investigations High throughput improves efficiency Reliable and proven technology Following the requirement for cell-based assay and phenotypic ...

Investment analysts at William Blair issued their Q1 2026 earnings estimates for MaxCyte in a report released on Wednesday, March 12th. William Blair analyst M. Larew expects that the company will ...

The Food Standards Agency (FSA) has started work on assessing the safety of lab-grown meat but only a minority of consumers ...

A research team led by Prof. Sun Cheng from the University of Science and Technology of China (USTC), in collaboration with researchers from the Agency for Science, Technology and Research and Chinese ...

carry out several single-cell assays, and export target cells based on particular outcomes. The Beacon ® optofluidic platform maintains the diversity of B cells, producing high-quality positive ...

Momentum Biotechnologies has acquired OmicScouts GmbH, a Munich-based CRO specialized in the field of mass spectrometry-based ...

Cellular immunogenicity and immunotoxicity assays help scientists design, validate, and translate therapeutic research into treatments that weaponize the immune response against cancer.